Paper35190830
Diurnal Expression of PD-1 on Tumor-Associated Macrophages Underlies the Dosing Time-Dependent Antitumor Effects of the PD-1/PD-L1 Inhibitor BMS-1 in B16/BL6 Melanoma-Bearing Mice.
Tsuruta A and 6 others. Mol Cancer Res, 2022. Cited by 79 papers, by iCite.
Cite this record
ConductScience Library. Diurnal Expression of PD-1 on Tumor-Associated Macrophages Underlies the Dosing Time-Dependent Antitumor Effects of the PD-1/PD-L1 Inhibitor BMS-1 in B16/BL6 Melanoma-Bearing Mice. Papers, record 35190830. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35190830
- Cell line
- RAW 264.7365 papers
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Diurnal Expression of PD-1 on Tumor-Associated Macrophages Underlies the Dosing Time-Dependent Antitumor Effects of the PD-1/PD-L1 Inhibitor BMS-1 in B16/BL6 Melanoma-Bearing Mice.
- PubMed
Connected records3
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Melanoma, Experimental | Major topic |
| Tumor-Associated Macrophages | Major topic |
| Animals | |
| B7-H1 Antigen | |
| Humans | |
| Immune Checkpoint Inhibitors | |
| Mice | |
| NF-kappa B | |
| Programmed Cell Death 1 Receptor | |
| Tumor Microenvironment |
Source PubMed
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12354771 | Identification of functional hypoxia response elements in the promoter region of the DEC1 and DEC2 genes. | J Biol Chem | 2002 | https://conductscience.org/library/papers/12354771 | PubMed |
| 2 | 31708917 | Pan-Cancer Analysis Reveals Disrupted Circadian Clock Associates With T Cell Exhaustion. | Front Immunol | 2019 | https://conductscience.org/library/papers/31708917 | PubMed |
| 3 | 1396582 | Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. | EMBO J | 1992 | https://conductscience.org/library/papers/1396582 | PubMed |
| 4 | 15824085 | Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers. | J Exp Med | 2005 | https://conductscience.org/library/papers/15824085 | PubMed |
| 5 | 17082649 | Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. | J Immunol | 2006 | https://conductscience.org/library/papers/17082649 | PubMed |
| 6 | 29735553 | Optimized Dosing Schedule Based on Circadian Dynamics of Mouse Breast Cancer Stem Cells Improves the Antitumor Effects of Aldehyde Dehydrogenase Inhibitor. | Cancer Res | 2018 | https://conductscience.org/library/papers/29735553 | PubMed |
| 7 | 31050774 | Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs. | JAMA Netw Open | 2019 | https://conductscience.org/library/papers/31050774 | PubMed |
| 8 | 29379212 | NF-κB, inflammation, immunity and cancer: coming of age. | Nat Rev Immunol | 2018 | https://conductscience.org/library/papers/29379212 | PubMed |
| 9 | 19955445 | A circadian clock in macrophages controls inflammatory immune responses. | Proc Natl Acad Sci U S A | 2009 | https://conductscience.org/library/papers/19955445 | PubMed |
| 10 | 30487606 | FBXO38 mediates PD-1 ubiquitination and regulates anti-tumour immunity of T cells. | Nature | 2018 | https://conductscience.org/library/papers/30487606 | PubMed |
| 11 | 28538141 | Cancer cell and macrophage cross-talk in the tumor microenvironment. | Curr Opin Pharmacol | 2017 | https://conductscience.org/library/papers/28538141 | PubMed |
| 12 | 22895791 | Core circadian protein CLOCK is a positive regulator of NF-κB-mediated transcription. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/22895791 | PubMed |
| 13 | 22437938 | Coordinated regulation of myeloid cells by tumours. | Nat Rev Immunol | 2012 | https://conductscience.org/library/papers/22437938 | PubMed |
| 14 | 26797126 | Circadian Clock in a Mouse Colon Tumor Regulates Intracellular Iron Levels to Promote Tumor Progression. | J Biol Chem | 2016 | https://conductscience.org/library/papers/26797126 | PubMed |
| 15 | 32726159 | Out of breath, out of time: interactions between HIF and circadian rhythms. | Am J Physiol Cell Physiol | 2020 | https://conductscience.org/library/papers/32726159 | PubMed |
| 16 | 26406148 | Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma. | N Engl J Med | 2015 | https://conductscience.org/library/papers/26406148 | PubMed |
| 17 | 32843638 | The updated landscape of tumor microenvironment and drug repurposing. | Signal Transduct Target Ther | 2020 | https://conductscience.org/library/papers/32843638 | PubMed |
| 18 | 30388137 | Tumor-immune profiling of murine syngeneic tumor models as a framework to guide mechanistic studies and predict therapy response in distinct tumor microenvironments. | PLoS One | 2018 | https://conductscience.org/library/papers/30388137 | PubMed |
| 19 | 27079802 | Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy. | Nat Rev Cancer | 2016 | https://conductscience.org/library/papers/27079802 | PubMed |
| 20 | 28514441 | PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity. | Nature | 2017 | https://conductscience.org/library/papers/28514441 | PubMed |
Cited by55
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 79 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42928018 | Roles of macrophages in tumor immunotherapy: metabolism, immune checkpoints, and combination strategies. | J Zhejiang Univ Sci B | 2026 | https://conductscience.org/library/papers/42928018 | PubMed |
| 42828155 | Early time-of-day infusion of PD-1 inhibitor improves prognosis in advanced gastric cancer: a multicenter real-world study. | Front Immunol | 2026 | https://conductscience.org/library/papers/42828155 | PubMed |
| 42788839 | Circadian timing of first-line chemoimmunotherapy is associated with survival in extensive-stage small cell lung cancer. | Oncoimmunology | 2026 | https://conductscience.org/library/papers/42788839 | PubMed |
| 42736417 | Unlocking the clock: a systematic review and meta-analysis on optimizing immune checkpoint inhibitor timing for advanced solid tumors. | Br J Cancer | 2026 | https://conductscience.org/library/papers/42736417 | PubMed |
| 42729373 | Impact of time-of-day and timing interval of neoadjuvant immunotherapy and chemotherapy infusions among patients with operable NSCLC using the inverse probability of treatment weighting method: a dual-center, retrospective study. | Front Immunol | 2026 | https://conductscience.org/library/papers/42729373 | PubMed |
| 42681659 | The circadian architecture of tumor immunity: mechanistic insights and treatment strategies. | Biomark Res | 2026 | https://conductscience.org/library/papers/42681659 | PubMed |
| 42662830 | Synchronizing immunity with time: unlocking the potential of chrono-immunotherapy in cancer. | Front Immunol | 2026 | https://conductscience.org/library/papers/42662830 | PubMed |
| 42578259 | Circadian Rhythms in Colorectal Cancer: Recent Advances in Development and Treatment. | J Clin Med Res | 2026 | https://conductscience.org/library/papers/42578259 | PubMed |
| 42371094 | Timing of immune checkpoint inhibitors infusion and prognosis in recurrent/metastatic nasopharyngeal carcinoma: a single-center, retrospective study. | Cancer Immunol Immunother | 2026 | https://conductscience.org/library/papers/42371094 | PubMed |
| 42328444 | Targeting the exosomal CaMK2A-ZDHHC3-GPX4 pathway reprograms tumor-associated macrophages and enhances anti-PD-1/PD-L1 immunotherapy in gastric cancer. | Int J Biol Sci | 2026 | https://conductscience.org/library/papers/42328444 | PubMed |
| 42316066 | Real-world evidence for the impact of circadian clock on the benefit from immune checkpoint inhibitors in solid tumors. | BMC Cancer | 2026 | https://conductscience.org/library/papers/42316066 | PubMed |
| 42134900 | Morning versus afternoon administration of immune checkpoint inhibitors in metastatic non-small-cell lung cancer. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/42134900 | PubMed |
| 42129307 | Circadian engineering of in vivo CAR T cell therapy for precision oncology. | NPJ Precis Oncol | 2026 | https://conductscience.org/library/papers/42129307 | PubMed |
| 42122266 | Impact of Blood Type and Administration Timing on Therapeutic Outcomes of Immune Checkpoint Inhibitors for Patients with Lung Cancer in the Chinese Alpine Region. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42122266 | PubMed |
| 42084869 | Time-of-Day Immunotherapy Administration and Outcomes in Advanced Cancers: A Systematic Review and Meta-Analysis. | JAMA Netw Open | 2026 | https://conductscience.org/library/papers/42084869 | PubMed |
| 42074080 | Therapeutic Strategies Targeting the Kidney-Liver-Immune-Heart Network: Circadian and Mechanosensory Pathways in CKD-Associated Cardiac Injury. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42074080 | PubMed |
| 41929252 | Hericenone C exhibits anti-nociceptive effects through RORα-mediated suppression of TLR4 transcription. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/41929252 | PubMed |
| 41777887 | Chrono-immunotherapy's current and future optimization strategies: immunotherapy timing in line with the circadian rhythm brings longer survival benefits. | Front Immunol | 2026 | https://conductscience.org/library/papers/41777887 | PubMed |
| 41738042 | Temporal dynamics in cancer immunotherapy: the interplay between circadian rhythms, tumor microenvironment, and immune checkpoint blockade. | J Natl Cancer Cent | 2026 | https://conductscience.org/library/papers/41738042 | PubMed |
| 41608568 | Nanobody Nb07 mitigates sepsis by blocking the PFKM-p53-PD-1 axis to enhance macrophage phagocytosis. | Theranostics | 2026 | https://conductscience.org/library/papers/41608568 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD274 | 29126 | PubTator's text mining | https://conductscience.org/library/genes/29126 | NCBI Gene |
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35190830
GET https://conductscience.org/api/papers/v1/35190830/references?page=2